Evidence map›Paper›PMID 38613045›Full record

Trial reportNutrients2024

Glycoprotein Matrix Zinc Exhibits Improved Absorption: A Randomized Crossover Trial.

Ralf Jäger, Martin Purpura, Jaci Davis, Nikolas Keratsopoulos, Mandy E Parra, Ariane H Secrest, Grant M Tinsley, Lem Taylor

Open access · goldAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Nutrients, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ralf JägerIncrenovo LLC, Whitefish Bay, WI 53217, USA.ORCID 0000-0002-7345-9635
Martin PurpuraIncrenovo LLC, Whitefish Bay, WI 53217, USA.ORCID 0000-0003-2591-5453
Jaci DavisHuman Performance Lab, School of Exercise and Sport Science, University of Mary Hardin-Baylor, Belton, TX 76513, USA.
Nikolas KeratsopoulosHuman Performance Lab, School of Exercise and Sport Science, University of Mary Hardin-Baylor, Belton, TX 76513, USA.
Mandy E ParraHuman Performance Lab, School of Exercise and Sport Science, University of Mary Hardin-Baylor, Belton, TX 76513, USA.ORCID 0000-0003-4258-692X
Ariane H SecrestSchool of Health Professions, University of Mary Hardin-Baylor, Belton, TX 76513, USA.
Grant M TinsleyEnergy Balance & Body Composition Laboratory, Department of Kinesiology & Sport Management, Texas Tech University, Lubbock, TX 79409, USA.ORCID 0000-0002-0230-6586
Lem TaylorHuman Performance Lab, School of Exercise and Sport Science, University of Mary Hardin-Baylor, Belton, TX 76513, USA.ORCID 0000-0003-4694-4712
University of Mary Hardin–Baylor · USTexas Tech University · US

Funding

Ashland (United States) N/A
6 · The paper itself

Abstract

Biotransformation of minerals via glycosylation by microorganisms such as yeast and/or probiotics yields nutrients bound to a food matrix, resulting in increased bioavailability. The purpose of this study was to compare the effects of glycoprotein matrix-bound zinc (GPM) on absorption compared to inorganic zinc oxide. Sixteen participants ingested 11 mg of zinc as either GPM™ Soy-Free Zinc (GPM, Ashland, Kearny, NJ, USA) or zinc oxide (USP). Blood samples were taken at 0 (i.e., baseline), 30, 60, 90, 120, 180, 240, 300, 360, 420, and 480 min post-ingestion. GPM zinc concentrations were significantly higher at 120 min (

Indexed as

ProbioticsZinc OxideCross-Over StudiesGlycoproteinsHumansSaccharomyces cerevisiaeZincGlycoproteinsZincZinc Oxideabsorptionpostbioticwhole-food nutrientszinc

Identifiers

PMID38613045
PMCPMC11013578
OpenAlexW4393356939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.